TOI Oncology Institute Inc
- Stocks
- Healthcare
- NASDAQ: TOI
Price (delayed)
$3.73
Market cap
$332.84M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$53,005
Enterprise value
$395.41M
Highlights
The EPS has grown by 22% YoY
TOI's revenue is up by 18% year-on-year and by 2.5% since the previous quarter
TOI's equity has dropped by 88% year-on-year but it is up by 41% since the previous quarter
The gross margin has contracted by 13% YoY but it has grown by 7% from the previous quarter
The quick ratio has contracted by 45% YoY and by 20% from the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities
Key stats
What are the main financial stats of TOI
Market
Valuations
Earnings
Shares outstanding
89.23M
Market cap
$332.84M
Enterprise value
$395.41M
Price to earnings (P/E)
N/A
Price to book (P/B)
55.74
Price to sales (P/S)
0.71
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.98
Revenue
$403.15M
Gross profit
$59.28M
Operating income
-$52.06M
Net income
-$64.36M
EBIT
-$53.28M
EBITDA
-$46.7M
Free cash flow
-$19.15M
Per share
Balance sheet
Liquidity
EPS
-$53,005
EPS diluted
-$53,005
Free cash flow per share
-$0.25
Book value per share
$0.07
Revenue per share
$5.23
TBVPS
$1.85
Total assets
$164M
Total liabilities
$158.93M
Debt
$102.31M
Equity
$5.07M
Working capital
$47.28M
Debt to equity
20.18
Current ratio
1.79
Quick ratio
1.5
Net debt/EBITDA
-1.34
Margins
Efficiency
Dividend
EBITDA margin
-11.6%
Gross margin
14.7%
Net margin
-16%
Operating margin
-12.9%
Return on assets
-37%
Return on equity
-482.6%
Return on invested capital
-30.1%
Return on capital employed
-51%
Return on sales
-13.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TOI stock price
How has the Oncology Institute stock price performed over time
Intraday
1.63%
1 week
1.36%
1 month
69.55%
1 year
578.18%
YTD
1,107.12%
QTD
81.95%
Financial performance
How have Oncology Institute's revenue and profit performed over time
Revenue
$403.15M
Gross profit
$59.28M
Operating income
-$52.06M
Net income
-$64.36M
Gross margin
14.7%
Net margin
-16%
Oncology Institute's operating margin has increased by 29% YoY and by 16% from the previous quarter
The company's net margin rose by 25% YoY and by 2.4% QoQ
TOI's revenue is up by 18% year-on-year and by 2.5% since the previous quarter
The operating income rose by 16% year-on-year and by 13% since the previous quarter
Price vs fundamentals
How does TOI's price correlate with its fundamentals
Growth
What is Oncology Institute's growth rate over time
Valuation
What is Oncology Institute stock price valuation
P/E
N/A
P/B
55.74
P/S
0.71
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.98
The EPS has grown by 22% YoY
TOI's equity has dropped by 88% year-on-year but it is up by 41% since the previous quarter
The P/S is 45% less than the 5-year quarterly average of 1.3
TOI's revenue is up by 18% year-on-year and by 2.5% since the previous quarter
Efficiency
How efficient is Oncology Institute business performance
The company's return on equity has shrunk by 67% QoQ
The ROS has grown by 31% YoY and by 9% from the previous quarter
The company's return on invested capital fell by 10% YoY and by 2.7% QoQ
The ROA is down by 9% year-on-year and by 5% since the previous quarter
Dividends
What is TOI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TOI.
Financial health
How did Oncology Institute financials performed over time
The total assets is 3.2% more than the total liabilities
The quick ratio has contracted by 45% YoY and by 20% from the previous quarter
The current ratio has contracted by 42% YoY and by 17% from the previous quarter
TOI's equity has dropped by 88% year-on-year but it is up by 41% since the previous quarter
The debt to equity has contracted by 41% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.